DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20200599

Clinical spectrum of facial hypermelanosis: a descriptive study from a tertiary care centre

Mohammed Thoyyib, Roshni Menon, Brinda G. David

Abstract


Background: Facial melanosis (FM) which refers to brown, black or blue pigmentation over the face is a common cosmetic concern in Indian patients. This increased incidence could be due to remarkable diversity of Indian ethinic population. Pigmentary disorders of the face are a great cosmetic and psychological concern for the patients.

Methods: This is an extensive descriptive clinico epidemiological study comprising of 1024 patients, conducted at Sri Venkateshwara Medical College Hospital and Research Centre, Puducherry, for a period of one and a half years. A detailed clinical history and examination was done, and all the clinical photographs and data were recorded. Necessary investigations like skin biopsy and patch testing was done wherever required.

Results: The maximum number of patients belong to the age group of 21-35 years with a female predominance (67.2%). Among patients of FM, post inflammatory pigmentation (35.3%) was the most common comprising of 362 patients, followed by melasma (17.2%), periorbital melanosis (15.7%), seborrheic melanosis (7.5%) followed by other causes.

Conclusions: FM is common in Indian skin, several of which have overlapping features, and some have defined clinical classification. Additionally, climatic conditions, cosmetic usage and social parameters predispose to the increased incidence of FM.


Keywords


Facial hypermelanosis, Melasma, Post inflammatory hyperpigmentation

Full Text:

PDF

References


Pichardo R, Vallejos Q, Feldman SR, Schulz MR, Verma A, Quandt SA, et al. The prevalence of melasma and its association with quality of life in adult male Latino migrant workers. Int J Dermatol. 2009;48:22‑6.

Pawaskar MD, Parikh P, Markowski T, McMichael AJ, Feldman SR, Balkrishnan R. Melasma and its impact on health‑related quality of life in Hispanic women. J Dermatolog Treat. 2007;18:5‑9.

Freitag FM, Cestari TF. What causes dark circles under the eyes? J Cosmet Dermatol. 2007;6:211‑5.

Kavya M. Melasma: a clinico – epidemiology study. Inter J Bas Appl Med Sci. 2014;4(2):388-91.

Achar A, Rathi SK. Melasma: a clinic- epidemiological study of 312 cases. Ind J Dermatol. 2011;56(4):380.

Shah AN. A clinial, etiological and histopathologial study of acquired facial melanosis. Sch J App Med Sci. 2016;4(12D):4439-45.

Gupta M, Mahajan VK. Clinical profile of 300 men with facial hypermelanosis. J Dermatol Case Reports. 2017;11(2):20.

Taylor S, Grimes P, Lim J, Im S, Lui H. Postinflammatory hyperpigmentation. J Cutan Med Surg. 2009;13:183‑91.

Hassan I, Aleem S, Bhat YJ, Anwar P. A clinic-epidemiological study of facial melanosis pigment Int. 2015;2:34-40.

Jagannathan M, Sadagopan K, Ekkarakudy J, Anandan H. Clinico-epidemiological Study of Patients with Melasma in a Tertiary Care Hospital - A Prospective Study. Int J Sci Stud. 2017;4(11):117-20.

Sheth PB, Shah HA, Dave JN. Periorbital hyperpigmentation: a study of its prevalence, common causative factors and its association with personal habits and other disorders. Ind J Dermatol. 2014;59(2):151-7.

KrupaShankar DS, Somani VK, Kohli M, Sharad J, Ganjoo A, Kandhari S, et al. A cross-sectional, multicentric clinico-epidemiological study of melasma in India. Dermatol Ther. 2014;4(1):71-81.

Goh CL, Dlova CN. A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singapore. Singapore Med J. 1999;40:455‑8.

Sanchez NP, Pathak MA, Sato S, Fitzpatrick TB, Sanchez JL, Mihm Jr MC. Melasma: a clinical, light microscopic, ultrastructural, and immune-fluorescence study. J Am Acad Dermatol. 1981;4(6):698-710.

Thappa DM. Melasma (Chloasma): A review with current treatment options. Ind J Dermatol. 2004;49:165‑6.

Kalasambas A, Antonio C. Melasma: Classification and treatment. J Eur Acad Dermatol Venerol 1995;4:217‑23.

Grimes PE. Melasma. Etiologic and therapeutic considerations. Arch Dermatol. 1995;131:1453‑7.